I am thinking that people with cancer would definitely know about and watch Cancer Today, because it is a program that focuses on a disease that they have and breakthroughs in its treatment and diagnosis. Given that so many people have this awful disease, you may be dramatically underestimating the number of viewers that will be exposed to the Recaf technology resulting from the broadcast. Adelphia and Time Warner carry the program, along with other cable companies; and their website gives access to all of the programing that is aired.
Therefore, I don't see how you can put this media exposure in the same category as Lebed. You seem to be lumping the bad pr decisions in with all of Biocurex's investment decisions, even the potentially good ones. I think that this exposure could possibly lead to more exposure in the field, more investment interest and more media coverage in the future by big T.V. networks. We'll see.
There was some conjecture that this media coverage might also be paid for by Biocurex. Is there anyone that can offer any evidence of this, or is it just postulation?
In any case, who can argue that things within the company aren't turning for the positive, with more great news ahead?
News 
Market Data 
Discover 
